Back to NISA Investment Advisors, LLC NISA Investment Advisors, LLC

IMVT

24 quarters

Position history for NISA Investment Advisors, LLCNISA Investment Advisors, LLC's holdings in Immunovant, Inc.

Yes. NISA Investment Advisors holds 4,472 shares of IMVT (Immunovant), worth $151,064, as of its Q3 2026 13F filing. It increased the position by 165 shares (+3.8%) from Q2 2026. NISA Investment Advisors has held IMVT since Q4 2020, across 24 quarterly 13F filings.

Current Value

$151,064

Current Shares

4,472

Total Value Change

+$72,064

Total Shares Change

+2,772

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
4,472
+3.8%
$151,0640.0%$33.78
23
2026-Q2
Increased
4,307
+5.6%
$165,9490.0%$38.53
24
2026-Q1
Increased
4,077
+0.5%
$101,2730.0%$24.84
22
2025-Q4
Unchanged
4,058
0.0%
$103,1540.0%$25.42
0
2025-Q3
Increased
4,058
+2.3%
$65,4150.0%$16.12
21
2025-Q2
Decreased
3,966
-1.5%
$63,4560.0%$16.00
0
2025-Q1
Increased
4,026
+0.4%
$68,8040.0%$17.09
21
2024-Q4
Increased
4,009
+3.3%
$99,3030.0%$24.77
22
2024-Q3
Increased
3,882
+1.1%
$110,6760.0%$28.02
22
2024-Q2
Increased
3,838
+1.1%
$101,3230.0%$26.40
22
2024-Q1
Increased
3,797
+1.0%
$122,6810.0%$32.31
22
2023-Q4
Decreased
3,759
-2.6%
$158,3670.0%$42.13
0
2023-Q3
Unchanged
3,859
0.0%
$148,1470.0%$38.39
0
2023-Q2
Increased
3,859
+7.5%
$73,2050.0%$18.52
23
2023-Q1
Decreased
3,589
-38.5%
$56,0000.0%$15.47
0
2022-Q4
Increased
5,839
+0.7%
$104,0000.0%$17.75
22
2022-Q3
Increased
5,800
+20.8%
$59,0000.0%$5.38
25
2022-Q2
Increased
4,800
+1100.0%
$19,0000.0%$4.06
30
2022-Q1
Decreased
400
-90.0%
$2,0000.0%$5.50
0
2021-Q4
Decreased
4,020
-41.7%
$28,0000.0%$8.36
0
2021-Q3
Increased
6,900
+1625.0%
$60,0000.0%$8.82
34
2021-Q2
Unchanged
400
0.0%
$4,0000.0%$10.80
0
2021-Q1
Decreased
400
-76.5%
$6,0000.0%$15.00
0
2020-Q4
New
1,700
-
$79,0000.0%$49.33
30

Other major holders of IMVT: FMR LLC, RTW Investments, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used